Morphocell Technologies

Developer of an engineered liver for the treatment of liver diseases

placeMontreal, Montreal, Canada calendar_todayFounded 2018 groups9 employees language morphocell.com

Social engagement

Social engagement: 5K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include CQDM, Invest Quebec, CDP Venture Capital, Genson Capital.

Investor typeCountShare
Venture capital250%
Accelerator & incubator125%
Other / undisclosed125%

Recent activity

11 Jun 2026
Leadership hire
Chief Financial Officer
14 May 2026
Expansion
Irvine, California
13 May 2026
Recognition
Coming soon